Focus of Work
Bio
Our translational laboratory research focuses on inflammation, fibrosis, tissue repair and regeneration. Aberrant tissue repair is prominent in autoimmune diseases (scleroderma, myositis, lupus) and in organ-based disorders (pulmonary and liver fibrosis, glomerulosclerosis, cardiac fibrosis, hypertrophic scar and radiotherapy injury), and are currently considered intractable. Aberrant tissue regeneration also underlie aging and obesity. Fibrosis contributes to greater than 30% of all death world...[Read full text]Our translational laboratory research focuses on inflammation, fibrosis, tissue repair and regeneration. Aberrant tissue repair is prominent in autoimmune diseases (scleroderma, myositis, lupus) and in organ-based disorders (pulmonary and liver fibrosis, glomerulosclerosis, cardiac fibrosis, hypertrophic scar and radiotherapy injury), and are currently considered intractable. Aberrant tissue regeneration also underlie aging and obesity. Fibrosis contributes to greater than 30% of all death worldwide, and thus represents a compelling and urgent scientific challenge.
We believe that fibrosis is in fact potentially reversible as well as preventable. To advance the development of effective anti-fibrotic interventions, we need to understand the cells, molecules, pathways and genes underlying the development, progression and resolution of fibrosis. To this end, we study inflammation, macrophage and vascular biology, extracellular matrix, stromal cell progenitors and mesenchymal stem cells, and the dynamic interplay between them.
Building on my experience as a practicing clinician and basic scientist, my laboratory takes an integrated "systems-biology" multi-disciplinary approach to inflammation and fibrosis. We use human tissue, genetic materials and animal models and cell biology and computational approaches to discover and validate novel targets for therapy, identify genetic risk factors and biomarkers. We then seek to translate these discoveries into clinically relevant approaches and assess them in human clinical trials. Our translational research leverages the unique resources of our data-rich patient registry and biorepository, as well as the NUGene DNA bank. We have extensive intra- and extramural collaborations, and thrive on a team research approach. Current extra-mural research partners include University of Pittsburgh, Washington University, Brigham and Women's Hospital, Medical University of South Carolina, Yale University, Southwestern, Cleveland Clinic, Virginia Commonwealth and the Mayo Clinic, as well as the NIH.[Shorten text]
Keywords
Select a keyword to see all related Feinberg faculty via the main faculty profile site.
Education and Certification
- MD: New York University (1980)
- Residency: Rhode Island Hospital (1983)
- Fellowship: Boston University Medical Center (1985)
- Board Certification: Internal Medicine, Rheumatology
Contact
Clinic (for patients): 312-695-8628
Administrative office: 312-503-8003
McGaw Pavilion Suite M-300
240 E Huron
Chicago IL 60611
